Intuitive Surgical Gains 1.13% on $840M Volume, 136th in U.S. Trading Rank

On October 2, 2025, Intuitive Surgical (ISRG) closed with a 1.13% gain, trading on a volume of $840 million—a 23.08% decline from the previous day’s activity. The stock ranked 136th in trading volume among U.S. equities, indicating moderate but active market participation. Analysts noted the move reflected sector-specific dynamics amid mixed macroeconomic signals, with healthcare technology stocks showing relative resilience compared to broader market fluctuations.

Recent developments centered on Intuitive’s product pipeline and competitive positioning. A key catalyst emerged from updated guidance on the company’s next-generation da Vinci surgical systems, with management signaling potential cost efficiencies in manufacturing. While no formal earnings updates were released, industry observers highlighted the stock’s performance as a barometer for investor sentiment toward high-margin medical device innovation. Short-term momentum appeared driven by strategic partnerships in emerging markets, though long-term risks remain tied to regulatory scrutiny and pricing pressures in core markets.

To run this back-test robustly I’ll need to pin down a few practical details and assumptions: 1. Trading universe • “All U.S. listed common stocks” (≈4,000 names) – or a narrower universe such as the Russell 3000 or S&P 500? 2. Entry/exit price convention • Buy at the close, sell at next-day close (typical for a 1-day hold), or enter at next-day open? 3. Weighting scheme • Simple equal-weight across the 500 names chosen each day, or volume-weighted / dollar-neutral, etc.? 4. Transaction cost & slippage assumptions (if any). 5. Benchmark (e.g., SPY) for relative-performance statistics. Once these points are clear I can generate the daily “buy list”, feed it into the strategy engine, and return the performance report. Let me know your preferences and I’ll proceed.